| Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease (NCT02760368) | R-Pharm International, LLC | 2016-05-19 |
| Effect of Subcutaneous ACTEMRA on Inflamed Atherosclerotic Plaques in Patients With Rheumatoid Arthritis (NCT02659150) | Massachusetts General Hospital | 2016-05-18 |
| Korean Post-marketing Surveillance for Xeljanz (NCT02984020) | Pfizer | 2016-05-13 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of AZD9567. (NCT02760316) | AstraZeneca | 2016-05-02 |
| Patient Reported Outcomes Reported Via PC / Tablet Home Versus Touch Screen at Hospital Among Patients With Arthritis (NCT02818478) | Henrik Gudbergsen | 2016-05-01 |
| Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial) (NCT02538341) | University of Alabama at Birmingham | 2016-05-01 |
| Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in China (NCT02668640) | AbbVie | 2016-05-01 |
| The Effects of a Six-week Exercise Programme Undertaken by Women With Rheumatoid Arthritis (NCT02819830) | Siobhan Graham | 2016-05-01 |
| VEGA Prospective Kiel (NCT02802085) | Aesculap AG | 2016-05-01 |
| Multiple Doses Escalation Study of SHR0302 in Rheumatoid Arthritis (RA) Patients (NCT02665910) | Jiangsu HengRui Medicine Co., Ltd. | 2016-05-01 |
| Oral Metagenomic Biomarkers in Rheumatoid Arthritis (NCT02544334) | University of Florida | 2016-05-01 |
| Analysis of B Cells From Autoimmune Individuals (NCT02747277) | University of Colorado, Denver | 2016-05-01 |
| Patient-Centred Innovations for Persons With Multimorbidity - Quebec (NCT02789800) | Université de Sherbrooke | 2016-04-22 |
| Effects of Social Networking on Chronic Disease Management in Arthritis (NCT02717403) | M.D. Anderson Cancer Center | 2016-04-07 |
| Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE) (NCT02750800) | AbbVie | 2016-04-07 |
| Comprehensive Segmental Revision System (NCT03270982) | Zimmer Biomet | 2016-04-01 |
| A Study to Evaluate the Long-term Safety and Efficacy of LBEC0101 in Subjects With Active RA Despite Methotrexate (MTX) (NCT02715908) | LG Life Sciences | 2016-04-01 |
| Usability of an AI for M923 in Subjects With Moderate to Severe RA (NCT02722044) | Momenta Pharmaceuticals, Inc. | 2016-04-01 |
| Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis (NCT02744755) | Sandoz | 2016-03-31 |
| Prospective Study of Patients With Rheumatoid Arthritis After the Age of 65 (NCT02686320) | Assistance Publique - Hôpitaux de Paris | 2016-03-29 |
| Study to Compare the Efficacy of Tocilizumab With or Without Glucocorticoid Discontinuation in Rheumatoid Arthritis Participants (NCT02573012) | Hoffmann-La Roche | 2016-03-29 |
| A Comparative Study to Observe the Effect of Concomitant Use of Corticosteroid Treatment in Rheumatoid Arthritis (RA) Participants Who Are Treated With a Tumor Necrosis Factor (TNF) Inhibitor or Tocilizumab (TCZ) as Their Second Biological Treatment. (NCT02679001) | Hoffmann-La Roche | 2016-03-24 |
| A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis (RA) Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and Have an Inadequate Response to csDMARDs (NCT02720523) | AbbVie | 2016-03-22 |
| Tocilizumab Real-Life Human Factors (RLHFs) Validation Study (NCT02682823) | Hoffmann-La Roche | 2016-03-21 |
| A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) With an Inadequate Response or Intolerance to Biologic DMARDs (NCT02706847) | AbbVie | 2016-03-15 |
| Vaccination Against Pneumococcal in Naïve Abatacept Rheumatoid Arthritis Patients (NCT02547493) | University Hospital, Montpellier | 2016-03-03 |
| All Polyethylene Tibia-VEGA Kiel (NCT02756702) | Aesculap AG | 2016-03-01 |
| Validation of Self-administered Questionnaire for Assessing Calcium Intake in Patients With Multiple Sclerosis or Chronic Inflammatory Arthritis (NCT02636829) | Centre Hospitalier Universitaire de Nīmes | 2016-03-01 |
| Fibrocytes in Early and Longstanding Rheumatoid Arthritis (NCT02652299) | Odense University Hospital | 2016-03-01 |
| Role of the ANS Dysregulation in the Persistence of Fatigue in Rheumatoid Arthritis Patients Treated With Anti-TNF (NCT02475486) | Centre Hospitalier Universitaire de Saint Etienne | 2016-02-25 |
| A Study to Compare Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have Not Previously Taken Methotrexate (NCT02706873) | AbbVie | 2016-02-23 |
| Musculoskeletal Ultrasound Assessment of Therapeutic Response of Tofacitinib in Rheumatoid Arthritis Patients (NCT02321930) | University of California, Los Angeles | 2016-02-16 |
| Efficacy and Safety Study of BMS-986142 in Patients With Moderate to Severe Rheumatoid Arthritis (NCT02638948) | Bristol-Myers Squibb | 2016-02-16 |
| Discrepancies Between Patients and Physicians in Their Perceptions of Rheumatoid Arthritis Disease Activity (NCT02924623) | Centre Hospitalier Universitaire de Nīmes | 2016-02-01 |
| Real Life Evaluation of Rheumatoid Arthritis Patients in Israel Treated With HUMIRA (NCT02322723) | AbbVie | 2016-02-01 |
| Evaluation of Tumour Necrosis Factor Alpha (TNFα) Blockers in Early Rheumatoid Arthritis in France (NCT02927509) | Centre Hospitalier Universitaire de Nīmes | 2016-02-01 |
| BOW015 (Infliximab-EPIRUS) and Infliximab in Patients With Active Rheumatoid Arthritis: The UNIFORM Study (NCT02683564) | Epirus Biopharmaceuticals (Switzerland) GmbH | 2016-02-01 |
| Efficacy, Safety and Immunogenicity of Enerceptan Compared to Enbrel in Rheumatoid Arthritis (NCT03332719) | Gema Biotech S.A. | 2016-02-01 |
| A Randomised, Double-blind, Phase I/II Study to Evaluate the PK, PD, Safety, and Efficacy Between HLX01 and Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis and Inadequate Response to Treatment With DMARDs (NCT03355872) | Shanghai Henlius Biotech | 2016-02-01 |
| Study to Evaluate Safety and Pharmacokinetics of GS-4059 (Tirabrutinib) in Healthy Volunteers and Participants With Rheumatoid Arthritis (RA) (NCT02626026) | Gilead Sciences | 2016-01-26 |
| Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases (NCT02925351) | Jonsson Comprehensive Cancer Center | 2016-01-25 |
| Evaluation of TNFα Blockers Monotherapy in Early Rheumatoid Arthritis in France (NCT02927535) | Centre Hospitalier Universitaire de Nīmes | 2016-01-15 |
| Rheumatoid Arthritis Patients and Porphyromonas Gingivalis (NCT02905175) | Centre Hospitalier Universitaire de Saint Etienne | 2016-01-13 |
| Patient-Centred Innovations for Persons With Multimorbidity - Ontario (NCT02742597) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2016-01-12 |
| Comparative Clinical Trial of Efficacy and Safety of BCD-055 and Remicade® in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis (NCT02762838) | Biocad | 2016-01-01 |
| Supporting Patient Care With Electronic Resources in the United States (NCT02787538) | Massachusetts General Hospital | 2016-01-01 |
| Fibrocytes in Rheumatoid Arthritis, Asthma and Interstitial Lung-disease. (NCT02711657) | Odense University Hospital | 2016-01-01 |
| Human Umbilical Cord-Mesenchymal Stem Cells for Rheumatoid Arthritis (NCT02643823) | Shenzhen Hornetcorn Bio-technology Company, LTD | 2016-01-01 |
| Effects of Case Management for Patients With Rheumatoid Arthritis in Taiwan (NCT06341348) | Dalin Tzu Chi General Hospital | 2016-01-01 |
| Study to Describe Real World Drug Retention Rate of the Tocilizumab at One Year (NCT02608112) | Hoffmann-La Roche | 2015-12-31 |
| Comparison of Combination Disease Modifying Antirheumatic Drugs With Methotrexate Therapy in Early Rheumatoid Arthritis (NCT02644499) | Jawaharlal Institute of Postgraduate Medical Education & Research | 2015-12-31 |
| Safety Study of Abatacept in Rheumatoid Arthritis Participants (NCT03696173) | Bristol-Myers Squibb | 2015-12-17 |
| A Study Comparing Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on a Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response to csDMARDs Alone (NCT02675426) | AbbVie | 2015-12-17 |
| NIR Fluorescence Imaging of Lymphatic Transport Using ICG (NCT02680067) | University of Rochester | 2015-12-08 |
| A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate (NCT02629159) | AbbVie | 2015-12-01 |
| Alendronate Treatment of Osteoporosis in Rheumatoid Arthritis (NCT02944799) | University of Aarhus | 2015-12-01 |
| Ultrasound as Imaging Biomarker of Early Response to Tocilizumab and Methotrexate in Very Early Rheumatoid Arthritis (NCT02837146) | Maria Stoenoiu | 2015-12-01 |
| Safety and Efficacy of Adipose Derived Stem Cells in Refractory Rheumatoid Arthritis, Systemic Lupus Erythematosus or Sharp's Syndrome (NCT02741362) | Arkansas Heart Hospital | 2015-12-01 |
| Blood Sample Collection Study for Pharmacogenomic Characterization of Participants That Previously Received Namilumab in M1-1188-002-EM (PRIORA, [NCT01317797]) Study (NCT02528786) | Takeda | 2015-11-19 |
| Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis (NCT02557100) | Bristol-Myers Squibb | 2015-11-19 |
| Real-World Outcome of Rheumatoid Arthritis Patients in Korea on Adalimumab (NCT02627924) | AbbVie | 2015-11-18 |
| A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD9567. (NCT02512575) | AstraZeneca | 2015-11-18 |
| Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in Taiwan (NCT02616380) | AbbVie | 2015-11-05 |
| Study to Compare the Efficacy and Safety of CELBESTA® and CELEBREX® in Patients With Rheumatoid Arthritis (NCT02780323) | Dong-A ST Co., Ltd. | 2015-11-02 |
| 99mTc-3PRGD2 SPECT/CT in Rheumatoid Arthritis Patients (NCT02723760) | First Affiliated Hospital of Fujian Medical University | 2015-11-01 |
| BC Study of G7 Cup and Compatible Femoral Stems (NCT03456622) | Zimmer Biomet | 2015-11-01 |
| Curcuma Longa L in Rheumatoid Arthritis (NCT02543931) | University of Arizona | 2015-11-01 |
| An Observational Study to Evaluate the Clinical Effectiveness, Quality of Life, Safety and Tolerability of Tocilizumab (TCZ) in Patients With Rheumatoid Arthritis (RA) in Daily Clinical Practice (NCT02552940) | Hoffmann-La Roche | 2015-10-31 |
| Validation of the French Version of the Health Assessment Questionnaire II (HAQ-II) for Rheumatoid Arthritis (NCT03249467) | Rennes University Hospital | 2015-10-17 |
| A Phase IV Study to Evaluate the Effect of Subcutaneous (SC) Tocilizumab Administered to Participants With Rheumatoid Arthritis (RA) Assessed Using Disease Activity Score (DAS28) (NCT02534311) | Hoffmann-La Roche | 2015-10-13 |
| Measuring the Impact of an Innovative Educational Intervention in Inflammatory Arthritis (NCT04606810) | CHU de Quebec-Universite Laval | 2015-10-01 |
| Evaluation of the Switch From the Original Infliximab to Its Biosimilar in Daily Practice at Cochin Hospital (NCT02998398) | Assistance Publique - Hôpitaux de Paris | 2015-10-01 |
| Hair Fall in Patients on Low Dose Methotrexate (NCT02591823) | Columbia Asia | 2015-10-01 |
| Analysis of Human Knee Joint Fluid Using Metabonomic, Genomic and Tribology Techniques (NCT02565160) | Imperial College London | 2015-10-01 |
| Comparing the Efficacy of Periarticular Bone Structure in Patients Treated With Either Tocilizumab or Tumor Necrosis Factor Blockers (NCT02778789) | University of Erlangen-Nürnberg Medical School | 2015-10-01 |
| Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade (NCT02605642) | Pfizer | 2015-09-10 |
| Effects of Abatacept in Patients With Early Rheumatoid Arthritis (NCT02504268) | Bristol-Myers Squibb | 2015-09-03 |
| Kunxian for the Treatment of Rheumatoid Arthritis (NCT02764515) | Chinese SLE Treatment And Research Group | 2015-09-01 |
| An Multicentre Clinical Study to Evaluate the Usability and Safety of the Pre-filled Pen and Pre-filled Syringe of SB5 in Subjects With Rheumatoid Arthritis (NCT02565810) | Samsung Bioepis Co., Ltd. | 2015-09-01 |
| Skeletal Muscle Dysfunction in Rheumatoid Arthritis (RA) (NCT02535832) | Ohio State University | 2015-09-01 |
| High Intensity Interval Training and Rheumatoid Arthritis (NCT02528344) | Duke University | 2015-09-01 |
| Safety, Tolerability, and Pharmacokinetics of a Single Oral Dose of SKI-O-703 in Healthy Volunteers (NCT02717988) | Oscotec Inc. | 2015-09-01 |
| Non-inferiority of Reduced-dose Rituximab in Rheumatoid Arthritis in Low Disease Activity and Remission (NCT05116228) | Medical University of Vienna | 2015-09-01 |
| Assessment of Tender & Swollen Joints Count Score Performed by a Rheumatologist And Rheumatology Nurses in Patients With RA and PsA. (NCT02556034) | Isabelle Fortin | 2015-09-01 |
| Causes of Comorbid Infertility Among Women With Rheumatoid Arthritis (NCT02313129) | Duke University | 2015-08-01 |
| IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA (NCT02451748) | University of Illinois at Chicago | 2015-08-01 |
| The Effect of Neurodynamic Mobilization Exercise on Lower Limb Pain in Patients With Rheumatoid Arthritis. (NCT02110940) | The Hong Kong Polytechnic University | 2015-08-01 |
| Mussels, Inflammation and Rheumatoid Arthritis (MIRA) (NCT02522052) | Göteborg University | 2015-08-01 |
| Tolerance, Pharmacokinetics and Preliminary Efficacy of T0001 in RA (Rheumatoid Arthritis) (NCT02481180) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2015-07-31 |
| Phenomics in Autoimmune and Inflammatory Diseases (NCT02466217) | Assistance Publique - Hôpitaux de Paris | 2015-07-29 |
| An ObserVatIonal STudy of the Effectiveness of AdaLimumab on Health and Disability Outcomes in New Zealand Patients With Immune-Mediated InflammaTorY Diseases (VITALITY) (NCT02451839) | AbbVie | 2015-07-06 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABBV-257 in Subjects With Rheumatoid Arthritis (NCT02531178) | AbbVie | 2015-07-01 |
| An Open-Label Extension Study Assessing the Long-Term Efficacy and Safety of ALX-0061 in Subjects With Rheumatoid Arthritis (NCT02518620) | Ablynx, a Sanofi company | 2015-07-01 |
| A Long Term Safety Extension Study (CHS-0214-05) (NCT02486939) | Coherus Oncology, Inc. | 2015-07-01 |
| Endothelial Dysfunction Evaluation for Coronary Heart Disease Risk Estimation in Rheumatoid Arthritis (EDRA Study) (NCT02341066) | Azienda Ospedaliero Universitaria di Sassari | 2015-07-01 |
| Patient-Reported Efficacy of Subcutaneous (SC) Abatacept in Rheumatoid Arthritis (RA) - South Africa (NCT02598466) | Bristol-Myers Squibb | 2015-07-01 |
| GP2013 Treatment in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera® (NCT02514772) | Sandoz | 2015-07-01 |
| Low-dose Recombinant Human IL-2 for the Treatment of Rheumatoid Arthritis (NCT02467504) | Peking University People's Hospital | 2015-07-01 |
| A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02). (NCT02480153) | Pfizer | 2015-06-25 |
| A Clinical Trial Study of Hip System in Primary Total Hip Arthroplasty in China (NCT02399007) | Johnson & Johnson Medical (Suzhou) Ltd. | 2015-06-07 |